PREDI-LYNCH kickoff meeting in Heidelberg: Bringing Europe together to tackle Lynch syndrome
The PREDI-LYNCH consortium officially launched its six-year Horizon Europe project with an in-person kickoff meeting in Heidelberg on September 18, 2025. The partners were welcomed by Project Coordinator Mev Dominguez-Valentin from the Institute for Cancer Research.
The event brought together more than 50 researchers, clinicians, and partners from across Europe. Funded under the EU Mission on Cancer, PREDI-LYNCH unites leading institutions and experts to improve screening, diagnostics, and risk prediction for individuals with a hereditary predisposition to cancer.
About PREDI-LYNCH:
The project “Validated non-invasive liquid biopsy tests for cancer PREDIction in LYNCH Syndrome, PREDI-LYNCH" is funded by the European Commission Horizon Europe Mission on Cancer with 13.6 million Euro.
PREDI-LYNCH will run for six years (2025-2031), and the consortium consists of 28 partners from 16 European countries.
The initiative is led by researcher Mev Dominguez-Valentin at the Institute for Cancer Research, Oslo University Hospital (OUH). The University of Oslo (UiO) and Oslo Cancer Cluster (OCC) are the other two Norwegian partners in the research and innovation project.
News article about the kickoff, from the Oslo Cancer Cluster homepage:
Bringing Europe together to tackle Lynch syndrome (oslocancercluster.no)
From the Oslo Cancer Cluster article:
Lynch syndrome is an inherited condition that increases a person’s risk of developing colorectal, endometrial, and several other cancers, often at a younger age than the general population. It’s one of the most common hereditary cancer syndromes, affecting about 1 in 300 people, yet many remain undiagnosed.
Early detection and tailored prevention can make a major difference for those living with the condition and their families.
“This is a long and complex journey that requires trust, dialogue, and shared commitment. Being together in person is essential for building that common ground,” said project coordinator Mev Dominguez Valentin from Oslo University Hospital.
Links:
PREDI-LYNCH (oslocancercluster.no)
Press Release:
PREDI-LYNCH - Validated non-invasive liquid biopsy tests for cancer PREDIction in LYNCH Syndrome (ous-research.no)
Inherited and Familial Cancer Project Group, headed by Mev Dominguez-Valentin